Tesamorlin Research Peptide COAs
View current and historical batch-specific testing results and Certificates of Analysis for Tesamorlin Research Peptide.
10MG
Tesamorlin Research Peptide batch testing
10MG Certificate of Analysis
10MG Certificate of Analysis
20MG
Tesamorlin Research Peptide batch testing
20MG Certificate of Analysis
20MG Certificate of Analysis
Testing Explanation
Tesamorelin batches are independently analyzed by
Freedom Diagnostics
to verify product identity, purity, and net peptide content.
The available certificates cover
Tesamorelin 10mg
and
Tesamorelin 20mg
batches, with identity confirmed as
Tesamorelin
through analytical testing.
Purity Standards
Verified Batch Results
For
Tesamorelin 10mg,
lot
2026-03-001-K1
reports
99.262% purity
with a measured net peptide content of
12.07 mg,
while lot
2026-03-002-K1
reports
99.85% purity
with a measured net peptide content of
10.40 mg.
For
Tesamorelin 20mg,
lot
2026-03-001-K2
reports
99.232% purity
with a measured net peptide content of
24.77 mg,
while lot
2026-03-002-K2
reports
99.82% purity
with a measured net peptide content of
20.30 mg.
Storage
Storage Information
Specific storage conditions are
not listed
on the Freedom Diagnostics Certificates of Analysis for these
Tesamorelin
batches. The corresponding lots are
2026-03-001-K1,
2026-03-002-K1,
2026-03-001-K2,
and
2026-03-002-K2.
Testing Methodology
HPLC + Mass Spectrometry
Analytical testing for all
Tesamorelin
batches was performed using
HPLC with UV detection coupled with mass spectrometry (LC-MS).
Mass spectrometry
was used to confirm the identity of
Tesamorelin,
while
HPLC-UV
reported purity results of
99.262%
and
99.85%
for the 10mg lots, and
99.232%
and
99.82%
for the 20mg lots.
Tesamorlin Research Peptide
View product information, specifications, research information and available variations.
View Tesamorlin Research Peptide